Scansource, Inc. (SCSC) · Sep 2, 2026 · Acquisition

ScanSource closes MicroAge acquisition, adding $225M in new borrowings

$220.5M acquisition — Previously announced all-cash deal; approximately $225M revolver borrowing

ScanSource completed its previously announced MicroAge acquisition for $220.5M cash, funded largely through a $225M revolving-credit draw.

The closing itself was already expected. The filing repeatedly describes MicroAge as a “previously announced acquisition,” so this 8-K confirms a scheduled transaction rather than introducing a surprise. 〔0〕

The new information is the funding and final cash mechanics. ScanSource paid $220.5 million at closing, with additional escrow amounts tied to purchase-price adjustments and indemnification claims (Item 2.03). It borrowed approximately $225 million under its revolving credit facility to fund the transaction.

ItemAmount / detail
Cash paid at closing$220.5 million (Item 2.03)
Purchase-price adjustment escrow$3 million (Item 2.03)
Indemnification escrow$6.8 million (Item 2.03)
Revolver borrowingApproximately $225 million (Item 2.03)

Net read: confirmation, not a beat or miss. The transaction adds scale but also makes the financing burden explicit; the filing provides no operating results, synergy update, repayment plan, or revised outlook to change the market’s view of the deal economics. With the acquisition already announced, the appropriate scorecard is a factual acquisition label and neutral polarity rather than a positive surprise.

Original filing on SEC EDGAR

More Scansource, Inc. news

ScanSource closes MicroAge acquisition, adding $225M in new borrowings | SCSC Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.